Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States.
@article{Roehler2019RegionalTI, title={Regional trends in suspected synthetic cannabinoid exposure from January 2016 to September 2019 in the United States.}, author={Douglas R. Roehler and Brooke E. Hoots and Alana M. Vivolo-Kantor}, journal={Drug and alcohol dependence}, year={2019}, volume={207}, pages={ 107810 } }
7 Citations
Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study
- MedicineMiddle East Current Psychiatry
- 2022
Adolescence are the most common users of SCs; neuro-psychiatric and cardiovascular side effects were the most experienced by subjects; and violence in many forms, especially domestic violence, was associated with synthetic cannabinoids abuse.
Cannabis and synthetic cannabinoid poison control center cases among adults aged 50+, 2009–2019
- MedicineClinical toxicology
- 2020
Although PCC cannabis cases involving older adults are relatively few, cases of other cannabis preparations than plant forms increased rapidly in recent years while cases of synthetic cannabinoids decreased.
Acute Kidney Injury Related to Intoxication From Synthetic Cannabis: Don’t You Know That You’re Toxic?
- MedicineCureus
- 2022
A case of a young male who presented with severe AKI that initially raised concern for the need to start renal replacement therapy is presented, and his renal function improved dramatically, and he was discharged home within days of presentation.
Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans.
- MedicineThe International journal on drug policy
- 2022
Management site and level of health care for cannabis- and synthetic cannabinoid-related poison control center cases involving older adults, 2016–2019
- MedicineDrug and chemical toxicology
- 2021
Between 2016 and 2019, PCC cannabis cases involving older adults increased twofold, largely due to cases of cannabidiol, edibles, and concentrated extracts, and stricter regulations for listing chemical ingredients and providing safety guidelines are needed for cannabis-derived products.
Using the Centers for Disease Control and Prevention's National Syndromic Surveillance Program Data to Monitor Trends in US Emergency Department Visits for Firearm Injuries, 2018 to 2019.
- MedicineAnnals of emergency medicine
- 2022
MECHANISMS OF SYNTHETIC CANNABINOIDS ON CARDIOVASCULAR HEALTH
- Biology, Medicine
- 2021
Mechanisms of Synthetic Cannabinoids on Cardiovascular Health are studied to establish an understanding of their role in human health and disease progression.
References
SHOWING 1-10 OF 19 REFERENCES
Severe Vitamin K‐Dependent Coagulopathy Associated With Contaminated Synthetic Cannabinoid Exposure in Illinois: 389
- MedicineAnnals of Emergency Medicine
- 2018
A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
- Medicine, PsychologyClinical toxicology
- 2016
To identify systematically the scientific reports of adverse events associated with the consumption of SCs in the medical literature and poison centre data, this work searched online databases and manually searched reference lists up to December 2014 to identify eligible studies.
An Outbreak of Synthetic Cannabinoid–Associated Coagulopathy in Illinois
- MedicineThe New England journal of medicine
- 2018
The data indicate that superwarfarin adulterants of synthetic cannabinoids can lead to clinically significant coagulopathy and in most of the cases in which the patient presented with bleeding diathesis, symptoms were controlled with the use of vitamin K1 replacement therapy.
“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB‐FUBINACA in New York
- MedicineThe New England journal of medicine
- 2017
The potency of the synthetic cannabinoid identified in these analyses is consistent with strong depressant effects that account for the “zombielike” behavior reported in this mass intoxication in New York City.
Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs.
- BiologyForensic science review
- 2014
There is growing toxicological and pharmacological evidence of impairment, psychosis, tissue injury, and isolated deaths attributable to this emerging class of drugs.
Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.
- Medicine, BiologyDrug and alcohol dependence
- 2014
Real-time monitoring of a mass K2-related overdose outbreak – Connecticut, 2018
- MedicineOnline Journal of Public Health Informatics
- 2019
Data from the EpiCenter system were consistent with reports from other data sources regarding this cluster of suspected drug overdoses, and a plan to improve coordinate real-time communication with stakeholders within DPH and with external partners during events is developed.
International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids
- MedicineBrain Research Bulletin
- 2016
Synthetic Pot: Not Your Grandfather's Marijuana.
- PsychologyTrends in pharmacological sciences
- 2017
2017 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 35th Annual Report
- MedicineClinical toxicology
- 2018
These data support the continued value of PC expertise and need for specialized medical toxicology information to manage more serious exposures, despite a decrease in cases involving lessserious exposures, according to the near real-time status of NPDS.